Long COVID-19 Pathophysiology: What Do We Know So Far?
Microorganisms · 30.09.2023 · 11 (10) · 2458
DOI: 10.3390/microorganisms11102458 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Microorganisms, online erschienen am 30.09.2023. Verfasst von Nikolaos-Renatos Tziolos und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine & Infectious Diseases, University Hospital of Heraklion, 71110 Heraklion, Greece. Die Arbeit wurde bisher 54-mal zitiert (Crossref) und nennt 159 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Long COVID-19 is a recognized entity that affects millions of people worldwide. Its broad clinical symptoms include thrombotic events, brain fog, myocarditis, shortness of breath, fatigue, muscle pains, and others. Due to the binding of the virus with ACE-2 receptors, expressed in many organs, it can potentially affect any system; however, it most often affects the cardiovascular, central nervous, respiratory, and immune systems. Age, high body mass index, female sex, previous hospitalization, and smoking are some of its risk factors. Despite great efforts to define its pathophysiology, gaps remain to be explained. The main mechanisms described in the literature involve viral persistence, hypercoagulopathy, immune dysregulation, autoimmunity, hyperinflammation, or a combination of these. The exact mechanisms may differ from system to system, but some share the same pathways. This review aims to describe the most prevalent pathophysiological pathways explaining this syndrome.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine & Infectious Diseases, University Hospital of Heraklion, 71110 Heraklion, Greece.
- School of Medicine, University of Crete, 71003 Heraklion, Greece.
ORCID-Profile: Nikolaos-Renatos Tziolos, Petros Ioannou, Diamantis P Kofteridis
Zitieren
APA
Tziolos, N. R., Ioannou, P., Baliou, S., & Kofteridis, D. P. (2023). Long COVID-19 Pathophysiology: What Do We Know So Far?. Microorganisms, 11(10), 2458. https://doi.org/10.3390/microorganisms11102458
Vancouver
Tziolos NR, Ioannou P, Baliou S, Kofteridis DP. Long COVID-19 Pathophysiology: What Do We Know So Far?. Microorganisms. 2023;11(10):2458. doi:10.3390/microorganisms11102458
BibTeX
@article{Tziolos2023,
author = {Tziolos, Nikolaos-Renatos and Ioannou, Petros and Baliou, Stella and Kofteridis, Diamantis P},
title = {Long COVID-19 Pathophysiology: What Do We Know So Far?},
journal = {Microorganisms},
year = {2023},
volume = {11},
number = {10},
pages = {2458},
doi = {10.3390/microorganisms11102458}
}
EUVIMED